{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:57:06Z","timestamp":1788508626934,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Erectile dysfunction (ED) is a prevalent condition with multifactorial etiology and significant impact on men\u2019s quality of life. Although standard therapies\u2014such as phosphodiesterase type 5 inhibitors, vacuum devices, and penile prostheses\u2014offer symptomatic relief, they do not address the underlying pathophysiology. Platelet-rich plasma (PRP), an autologous concentration of platelets and growth factors, has emerged as a potential regenerative treatment that may promote neurovascular repair and restore erectile function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of PRP monotherapy for the treatment of erectile dysfunction through a systematic review and meta-analysis of randomized controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, a comprehensive search of PubMed, EMBASE, Google Scholar, Cochrane Library, Scopus, and Web of Science was performed for RCTs assessing intracavernosal PRP injections in men with ED. Studies combining PRP with other regenerative therapies were excluded. Data were synthesized using a random-effects model to generate pooled standardized mean differences (SMDs) in International Index of Erectile Function (IIEF) scores at 1, 3, and 6\u00a0months. Risk of bias was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven RCTs including 512 participants were analyzed. PRP injection volumes ranged from 5 to 10\u00a0mL across 2-4 sessions. At 1\u00a0month, pooled SMD in IIEF was 0.28 (95% CI \u22120.11 to 0.67, P\u00a0=\u2009.16); at 3\u00a0months, it was 0.29 (95% CI \u22120.08 to 0.67, P\u00a0&amp;lt;\u2009.05); and at 6\u00a0months, it was 0.36 (95% CI \u22120.09 to 0.81, P\u00a0=\u2009.12). Heterogeneity was high (I2\u00a0=\u200974%-83%) across time points. Subgroup analyses showed no significant difference by risk of bias. PRP was well tolerated, with only isolated mild adverse events (hematoma, plaque formation) reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence does not support a consistent, clinically meaningful improvement in erectile function with PRP monotherapy compared with placebo. Despite an encouraging mechanistic rationale and safety profile, the high heterogeneity, small sample sizes, and methodological limitations of existing RCTs limit confidence in efficacy. Larger, standardized, double-blind trials with rigorous protocols are needed to clarify the role of PRP in ED management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf325","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:25:38Z","timestamp":1764084338000},"source":"Crossref","is-referenced-by-count":4,"title":["Current advances in platelet-rich plasma therapy for erectile dysfunction: a meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8953-6492","authenticated-orcid":false,"given":"Dayan","family":"Jacob","sequence":"first","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hay","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shariq","family":"Rahemtoola","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sim","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Libretto","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-896X","authenticated-orcid":false,"given":"Elia Abou","family":"Chawareb","sequence":"additional","affiliation":[{"name":"University of California , Department of Urology, Irvine, California, 92868 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Hammad","sequence":"additional","affiliation":[{"name":"University of California , Department of Urology, Irvine, California, 92868 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-999X","authenticated-orcid":false,"given":"Mohamed","family":"Mubarak","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal","family":"Yafi","sequence":"additional","affiliation":[{"name":"University of California , Department of Urology, Irvine, California, 92868 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Modgil","sequence":"additional","affiliation":[{"name":"Manchester Andrology Research Collaborative (MARC) , Department of Urology, Manchester , M13 9WL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2026010506163260600_ref1","first-page":"820","article-title":"Erectile dysfunction","volume":"94","author":"Rew","year":"2016","journal-title":"Am Fam Physician"},{"key":"2026010506163260600_ref2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"2026010506163260600_ref3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bju.14813","article-title":"The global prevalence of erectile dysfunction: a review","volume":"124","author":"Kessler","year":"2019","journal-title":"BJU Int"},{"key":"2026010506163260600_ref4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12610-024-00232-3","article-title":"Safety and efficacy of platelet-rich plasma injection for treatment of erectile dysfunction: a prospective randomized controlled study","volume":"34","author":"Ragheb","year":"2024","journal-title":"Basic Clin Androl"},{"key":"2026010506163260600_ref5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pharmthera.2004.11.011","article-title":"Nitric oxide and penile erectile function","volume":"106","author":"Toda","year":"2005","journal-title":"Pharmacol Ther"},{"key":"2026010506163260600_ref6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.ijir.3901581","article-title":"Physiological regulation of penile arteries and veins","volume":"20","author":"Prieto","year":"2008","journal-title":"Int J Impot Res"},{"key":"2026010506163260600_ref7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1743-6109.04038.x","article-title":"Physiology of erectile function","volume":"1","author":"S\u00e1enz de Tejada","year":"2004","journal-title":"J Sex Med"},{"key":"2026010506163260600_ref8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaad.2019.04.037","article-title":"Platelet-rich plasma and its utility in medical dermatology: a systematic review","volume":"81","author":"Hesseler","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026010506163260600_ref9","doi-asserted-by":"publisher","first-page":"CD006899","DOI":"10.1002\/14651858.cd006899.pub3","article-title":"Autologous platelet-rich plasma for treating chronic wounds","volume":"2016","author":"Martinez-Zapata","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010506163260600_ref10","doi-asserted-by":"publisher","first-page":"CD010071","DOI":"10.1002\/14651858.cd010071.pub3","article-title":"Platelet-rich therapies for musculoskeletal soft tissue injuries","volume":"2014","author":"Moraes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010506163260600_ref11","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1177\/0363546517743746","article-title":"The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment","volume":"46","author":"Chen","year":"2017","journal-title":"Am J Sports Med"},{"key":"2026010506163260600_ref12","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"2026010506163260600_ref13"},{"key":"2026010506163260600_ref14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"2026010506163260600_ref15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"2026010506163260600_ref16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2307\/2332378","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"2026010506163260600_ref17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026010506163260600_ref18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026010506163260600_ref19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.37506\/ijfmt.v17i1.18906","article-title":"Platelet rich plasma in erectile dysfunction a double-blind, randomized, placebo-controlled clinical trial","volume":"17","author":"Khalef","year":"2023","journal-title":"Ind J Forensic Med Toxicol"},{"key":"2026010506163260600_ref20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.urology.2023.01.028","article-title":"Is platelet rich plasma safe and effective in treatment of erectile dysfunction? Randomized controlled study","volume":"175","author":"Shaher","year":"2023","journal-title":"Urology"},{"key":"2026010506163260600_ref21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jsxm.2021.03.008","article-title":"Platelet-rich plasma (PRP) improves erectile function: a double-blind, randomized, placebo-controlled clinical trial","volume":"18","author":"Poulios","year":"2021","journal-title":"J Sex Med"},{"key":"2026010506163260600_ref22","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4227952\/v1","volume-title":"Is Platelet Rich Plasma a Safe and Effective Treatment in Erectile Dysfunction?","author":"Moubasher","year":"2024"},{"key":"2026010506163260600_ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33545\/26646617.2024.v6.i1a.27","article-title":"Platelet rich plasma: new therapy for erectile dysfunction","volume":"6","author":"Saleh","year":"2024","journal-title":"Int J Urol Res"},{"key":"2026010506163260600_ref24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/ju.0000000000003481","article-title":"Platelet-rich plasma for the treatment of erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled clinical trial","volume":"210","author":"Masterson","year":"2023","journal-title":"J Urol"},{"key":"2026010506163260600_ref25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41443-023-00798-y","article-title":"Platelet-rich plasma intracavernosal injections for the treatment of primary organic erectile dysfunction: a systematic review and meta-analysis of contemporary controlled studies","volume":"36","author":"Panunzio","year":"2023","journal-title":"Int J Impot Res"},{"key":"2026010506163260600_ref26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/frph.2022.944765","article-title":"Erectile dysfunction: is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence","volume":"4","author":"Anastasiadis","year":"2022","journal-title":"Front Reprod Health"},{"key":"2026010506163260600_ref27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","article-title":"Platelet-rich plasma (PRP): what is PRP and what is not PRP?","volume":"10","author":"Marx","year":"2001","journal-title":"Implant Dent"},{"key":"2026010506163260600_ref28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/jsm.0000000000000973","article-title":"American Medical Society for Sports Medicine position statement: principles for the responsible use of regenerative medicine in sports medicine","volume":"31","author":"Finnoff","year":"2021","journal-title":"Clin J Sport Med"},{"key":"2026010506163260600_ref29","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.arthro.2021.07.003","article-title":"Platelet-rich plasma: fundamentals and clinical applications","volume":"37","author":"Sheean","year":"2021","journal-title":"Arthroscopy"},{"key":"2026010506163260600_ref30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/prs.0000000000007509","article-title":"Platelet-rich plasma: evolving role in plastic surgery","volume":"147","author":"Chamata","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"2026010506163260600_ref31","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1111\/j.1743-6109.2012.02881.x","article-title":"The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model","volume":"9","author":"Wu","year":"2012","journal-title":"J Sex Med"},{"key":"2026010506163260600_ref32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/aja.2008.37","article-title":"The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model","volume":"11","author":"Ding","year":"2009","journal-title":"Asian J Androl"},{"key":"2026010506163260600_ref33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","article-title":"Applications of the regenerative capacity of platelets in modern medicine","volume":"64","author":"Cecerska-Hery\u0107","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"2026010506163260600_ref34","doi-asserted-by":"publisher","first-page":"e2214187","DOI":"10.1001\/jamanetworkopen.2022.14187","article-title":"Analysis of direct-to-consumer marketing of platelet-rich plasma for erectile dysfunction in the US","volume":"5","author":"Shahinyan","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2026010506163260600_ref35","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/cells9051250","article-title":"Revisiting the regenerative therapeutic advances towards erectile dysfunction","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"issue":"6","key":"2026010506163260600_ref36","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/ijms23063017","article-title":"Intracavernous injection of platelet-rich plasma therapy enhances erectile function and decreases the mortality rate in streptozotocin-induced diabetic rats","volume":"23","author":"Liao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026010506163260600_ref37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jsxmed\/qdae131","article-title":"Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression","volume":"21","author":"Hinojosa-Gonzalez","year":"2024","journal-title":"J Sex Med"},{"key":"2026010506163260600_ref38","doi-asserted-by":"publisher","first-page":"e0313074","DOI":"10.1371\/journal.pone.0313074","article-title":"Efficacy of platelet-rich plasma in the treatment of erectile dysfunction: a meta-analysis of controlled and single-arm trials","volume":"19","author":"Du","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"2026010506163260600_ref39","doi-asserted-by":"publisher","first-page":"2358944","DOI":"10.1080\/13685538.2024.2358944","article-title":"The efficacy of platelet rich plasma in the treatment of erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Mao","year":"2024","journal-title":"Aging Male"},{"issue":"4","key":"2026010506163260600_ref40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/sxmrev\/qeae018","article-title":"Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Deabes","year":"2024","journal-title":"Sex Med Rev"},{"key":"2026010506163260600_ref41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function Scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"2026010506163260600_ref42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.colsurfb.2017.10.046","article-title":"Distribution, recovery and concentration of platelets and leukocytes in L-PRP prepared by centrifugation","volume":"161","author":"Gomes","year":"2018","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"12","key":"2026010506163260600_ref43","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1177\/0363546515608481","article-title":"Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations","volume":"43","author":"Oh","year":"2015","journal-title":"Am J Sports Med"},{"issue":"2","key":"2026010506163260600_ref44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0363546517746112","article-title":"Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature","volume":"47","author":"Oudelaar","year":"2019","journal-title":"Am J Sports Med"},{"issue":"3","key":"2026010506163260600_ref45","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.esxm.2021.100343","article-title":"Restorative therapies for erectile dysfunction: position statement from the Sexual Medicine Society of North America (SMSNA)","volume":"9","author":"Liu","year":"2021","journal-title":"Sex Med"},{"issue":"1","key":"2026010506163260600_ref46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11420-016-9519-3","article-title":"Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition","volume":"13","author":"Degen","year":"2017","journal-title":"HSS J"},{"issue":"1","key":"2026010506163260600_ref47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1743-6109.2012.02825.x","article-title":"Standardization of vascular assessment of erectile dysfunction","volume":"10","author":"Sikka","year":"2013","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/1\/qdaf325\/65498189\/qdaf325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/1\/qdaf325\/65498189\/qdaf325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:16:41Z","timestamp":1767611801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/doi\/10.1093\/jsxmed\/qdaf325\/8342215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf325","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,25]]},"article-number":"qdaf325"}}